Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/29a3a63b717e403f85dd2fc3876d3939 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:29a3a63b717e403f85dd2fc3876d3939 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:29a3a63b717e403f85dd2fc3876d39392021-12-02T17:31:09ZAuthor Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 210.1038/s41467-020-16007-z2041-1723https://doaj.org/article/29a3a63b717e403f85dd2fc3876d39392020-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-16007-zhttps://doaj.org/toc/2041-1723An amendment to this paper has been published and can be accessed via a link at the top of the paper.Ryota TamuraMasato FujiokaYukina MorimotoKentaro OharaKenzo KosugiYumiko OishiMizuto SatoRyo UedaHirokazu FujiwaraTetsuro HikichiShinobu NojiNaoki OishiKaoru OgawaYutaka KawakamiTakayuki OhiraKazunari YoshidaMasahiro TodaNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-1 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Science Q |
| spellingShingle |
Science Q Ryota Tamura Masato Fujioka Yukina Morimoto Kentaro Ohara Kenzo Kosugi Yumiko Oishi Mizuto Sato Ryo Ueda Hirokazu Fujiwara Tetsuro Hikichi Shinobu Noji Naoki Oishi Kaoru Ogawa Yutaka Kawakami Takayuki Ohira Kazunari Yoshida Masahiro Toda Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 |
| description |
An amendment to this paper has been published and can be accessed via a link at the top of the paper. |
| format |
article |
| author |
Ryota Tamura Masato Fujioka Yukina Morimoto Kentaro Ohara Kenzo Kosugi Yumiko Oishi Mizuto Sato Ryo Ueda Hirokazu Fujiwara Tetsuro Hikichi Shinobu Noji Naoki Oishi Kaoru Ogawa Yutaka Kawakami Takayuki Ohira Kazunari Yoshida Masahiro Toda |
| author_facet |
Ryota Tamura Masato Fujioka Yukina Morimoto Kentaro Ohara Kenzo Kosugi Yumiko Oishi Mizuto Sato Ryo Ueda Hirokazu Fujiwara Tetsuro Hikichi Shinobu Noji Naoki Oishi Kaoru Ogawa Yutaka Kawakami Takayuki Ohira Kazunari Yoshida Masahiro Toda |
| author_sort |
Ryota Tamura |
| title |
Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 |
| title_short |
Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 |
| title_full |
Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 |
| title_fullStr |
Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 |
| title_full_unstemmed |
Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 |
| title_sort |
author correction: a vegf receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 |
| publisher |
Nature Portfolio |
| publishDate |
2020 |
| url |
https://doaj.org/article/29a3a63b717e403f85dd2fc3876d3939 |
| work_keys_str_mv |
AT ryotatamura authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT masatofujioka authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT yukinamorimoto authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT kentaroohara authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT kenzokosugi authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT yumikooishi authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT mizutosato authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT ryoueda authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT hirokazufujiwara authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT tetsurohikichi authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT shinobunoji authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT naokioishi authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT kaoruogawa authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT yutakakawakami authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT takayukiohira authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT kazunariyoshida authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT masahirotoda authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 |
| _version_ |
1718380662121037824 |